1. Department of Pharmacovigilance;
2. Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunkyō, Japan;
3. Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan;
4. Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
5. Department of Rheumatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan;
6. Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Bunkyō, Japan;
7. Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan;
8. Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Takamatsu, Japan,
9. Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan;
10. Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan;
11. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Minato, Japan;
12. Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Sagamihara, Japan;
13. Department of Internal Medicine, Center for Rheumatic Diseases, Dohgo Spa Hospital, Matsuyama, Japan;
14. The First Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan;
15. Department of Rheumatology, Soka Municipal Hospital, Saitama, Japan;
16. Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan